Literature DB >> 507969

Splenectomy for Gaucher's disease.

B Salky, I Kreel, I Gelernt, J Bauer, A H Aufses.   

Abstract

The records of ten patients who underwent splenectomy for Gaucher's disease were reviewed. All patients had the adult type of the disease. The indications for splenectomy were hypersplenism and mechanical problems. The hematological picture returned to normal in all cases and has remained so throughout the follow-up period. The different forms Gaucher's disease and specific diagnostic tests are discussed. Even though splenectomy is indicated when hematological and mechanical problems exist, selective enzymatic replacement therapy seems to be the preferred future mode of treatment.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 507969      PMCID: PMC1344537          DOI: 10.1097/00000658-197911000-00006

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  2 in total

1.  METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE.

Authors:  R O BRADY; J N KANFER; D SHAPIRO
Journal:  Biochem Biophys Res Commun       Date:  1965-01-18       Impact factor: 3.575

2.  The diagnosis of the adult type of Gaucher's disease and its carrier state by demonstration of deficiency of beta-glucosidase activity in peripheral blood leukocytes.

Authors:  E Beutler; W Kuhl
Journal:  J Lab Clin Med       Date:  1970-11
  2 in total
  5 in total

1.  Partial splenectomy for Gaucher's disease.

Authors:  B M Rodgers; C Tribble; A Joob
Journal:  Ann Surg       Date:  1987-06       Impact factor: 12.969

2.  Laparoscopic fenestration for a huge symptomatic splenic cyst in a patient with Gaucher's disease.

Authors:  Kyohei Abe; Hiroaki Shiba; Junichi Shimada; Shinji Onda; Taro Sakamoto; Katsuhiko Yanaga
Journal:  Clin J Gastroenterol       Date:  2018-03-23

3.  Partial splenectomy for massive splenomegaly secondary to Gaucher's disease.

Authors:  W E Thomas; D A Winfield
Journal:  Postgrad Med J       Date:  1991-12       Impact factor: 2.401

Review 4.  Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring.

Authors:  T M Cox; J M F G Aerts; N Belmatoug; M D Cappellini; S vom Dahl; J Goldblatt; G A Grabowski; C E M Hollak; P Hwu; M Maas; A M Martins; P K Mistry; G M Pastores; A Tylki-Szymanska; J Yee; N Weinreb
Journal:  J Inherit Metab Dis       Date:  2008-05-23       Impact factor: 4.982

5.  Recommendations for the management of the haematological and onco-haematological aspects of Gaucher disease.

Authors:  Derralynn Hughes; Maria Domenica Cappellini; Marc Berger; Jan Van Droogenbroeck; Maaike de Fost; Dragana Janic; Theodore Marinakis; Hanna Rosenbaum; Jesús Villarubia; Elena Zhukovskaya; Carla Hollak
Journal:  Br J Haematol       Date:  2007-07-26       Impact factor: 6.998

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.